Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Systemic and Local Anaphylaxis is Not Induced by Korean Red Ginseng Mixture in Guinea Pigs

  • Hyun, Sun Hee (Laboratory of Fundamental Research, Korea Ginseng Corporation) ;
  • Kyung, Jong Soo (Laboratory of Fundamental Research, Korea Ginseng Corporation) ;
  • Song, Yong Bum (Laboratory of Fundamental Research, Korea Ginseng Corporation) ;
  • So, Seung-Ho (Laboratory of Fundamental Research, Korea Ginseng Corporation) ;
  • Kim, Young Sook (Laboratory of Fundamental Research, Korea Ginseng Corporation)
  • Received : 2017.10.20
  • Accepted : 2018.04.30
  • Published : 2018.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Currently, injuries to customers due to health functional foods are annually increasing. To evaluate the antigenicity of Korean red ginseng mixture (KRGM), we tested for systemic anaphylactic shock and passive cutaneous anaphylaxis in guinea pigs. Based on a comparison of measured body weights, there were no changes in body weight for the KRGM treatment group compared with the control group. In the ovalbumin treated group, however, there was a statistically significant decrease in body weight. For the active systemic anaphylaxis test, after the induction, there were no symptoms that suggested anaphylactic shock in the control and KRGM treatment group. In the ovalbumin treated group, there were symptoms that suggested severe anaphylaxis, and those symptoms included restlessness, piloerection, tremor, rubbing or licking the nose, sneezing, coughing, hyperpnea, dyspnea, staggering gait, jumping, gasping and writhing, convulsion, side position and Cheyne-stokes respiration. All animals died within thirty minutes in the ovalbumin treated group. For the passive cutaneous anaphylaxis test in guinea pigs sensitized to KRGM, each anti-serum was diluted in a stepwise manner. This was followed by an intravenous injection of a mixture of KRGM and Evans blue. The results of the test showed that all the responses were negative in the control and the low-dose and high-dose administration groups. However, in the ovalbumin treated group, all the responses were positive. Based on the above results, there were no anaphylactic responses for up to 12 times the amount of human intake of KRGM in Hartley Guinea-pigs. The results suggest that KRGM is safe as measured by the systemic and local antigenicity in guinea pigs.

Keywords

References

  1. Kim, S.J. (1994) Immunology in Hypersensitivity. Korea medical press, Seoul, pp. 260-273.
  2. Segal, D.M., Taurog, J.D. and Metzger, H. (1977) Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc. Natl. Acad. Sci. U.S.A., 74, 2993-2997. https://doi.org/10.1073/pnas.74.7.2993
  3. Metzger, H., Alcaraz, G., Hohman, R., Kinet, J.P., Pribluda, V. and Quarto, R. (1986) The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol., 4, 419-470. https://doi.org/10.1146/annurev.iy.04.040186.002223
  4. Alber, G., Miller, L., Jelsema, C.L., Varin-Blank, N. and Metzger, H. (1991) Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J. Biol. Chem., 266, 22613-22620.
  5. Saito, H. and Nomura, Y. (1989) Screening methods for drug evaluation 3 in Pharmaceutical Research and Development (Suzuki, L., Tanaka, H., Yajima, H., Fukuda, H., Sezaki, H., Koga, K., Hirobe, M. and Nakajime, T. Eds.). Hirokawa, Tokyo, pp. 22.
  6. Chen, S., Gong, J., Liu, F. and Mohammed, U. (2000) Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology, 100, 471-480. https://doi.org/10.1046/j.1365-2567.2000.00045.x
  7. Yu, J.L., Dou, D.Q., Chen, X.H., Yang, H.Z., Guo, N. and Cheng, G.F. (2005) Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes. Planta Med., 71, 202-207. https://doi.org/10.1055/s-2005-837817
  8. Cho, J.Y., Kim, A.R., Yoo, E.S., Baik, K.U. and Park, M.H. (2002) Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Med., 68, 497-500. https://doi.org/10.1055/s-2002-32556
  9. Cho, J.Y., Yoo, E.S., Baik, K.U., Park, M.H. and Han, B.H. (2001) In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-a production and its modulation by known TNF-a antagonists. Planta Med., 67, 213-218. https://doi.org/10.1055/s-2001-12005
  10. Rhule, A., Navarro, S., Smith, J.R. and Shepherd, D.M. (2006) Panax notoginseng attenuates LPS-induced proinflammatory mediators in RAW264.7 cells. J. Etnopharmacol., 106, 121-128. https://doi.org/10.1016/j.jep.2005.12.012
  11. Lee, J.W., Takano-Ishikawa, Y., Watanabe, J., Kobori, M., Tsushida, T. and Yamaki, K. (2002) Effect of ginsenosides and red ginseng water extract on tumor necrosis factor-a production by rat peritoneal macrophages. Food Sci. Technol. Res., 8, 300-303. https://doi.org/10.3136/fstr.8.300
  12. Kenarova, B., Neychev, H., Hadjiivanova, C. and Petkov, V.D. (1990) Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn. J. Pharmacol., 54, 447-454. https://doi.org/10.1254/jjp.54.447
  13. Lee, E.J., Ko, E., Lee, J., Rho, S., Ko, S., Shin, M.K., Min, B.I., Hong, M.C., Kim, S.Y. and Bae, H. (2004) Ginsenoside Rg1 enhances CD4+ T-cell activities and modulates Th1/Th2 differentiation. Int. Immunopharmacol., 4, 235-244. https://doi.org/10.1016/j.intimp.2003.12.007
  14. Plohmann, B., Bader, G., Hiller, K. and Franz, G. (1997) Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie, 52, 953-957.
  15. Ro, J.Y., Ahn, Y.S. and Kim, K.H. (1998) Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. Int. J. Immunopharmacol., 20, 625-641. https://doi.org/10.1016/S0192-0561(98)00062-9
  16. Choo, K.M., Park, E.K., Han, M.J. and Kim, D.H. (2003) Antiallergic activity of ginseng and its ginsenosides. Planta Med., 69, 518-522. https://doi.org/10.1055/s-2003-40653
  17. Park, E.K., Choo, M.K., Han, M.J. and Kim, D.H. (2004) Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol., 133, 113-120. https://doi.org/10.1159/000076383
  18. Park, E.K., Choo, M.K., Kim, E.J., Han, M.J. and Kim, D.H. (2003) Antiallergic activity of ginsenoside Rh2. Biol. Pharm. Bull., 26, 1581-1584. https://doi.org/10.1248/bpb.26.1581
  19. Caruso, M., Frasca, G., Di Giuseppe, P.L., Pennisi, A., Tringali, G. and Bonina, F.P. (2008) Effects of a new nutraceutical ingredient on allergen-induced sulphidoleukotrienes production and CD63 expression in allergic subjects. Int. Immunopharmacol., 8, 1781-1786. https://doi.org/10.1016/j.intimp.2008.08.015
  20. Bae, E.A., Han, M.J., Shin, Y.W. and Kim, D.H. (2006) Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol. Pharm. Bull., 29, 1862-1867. https://doi.org/10.1248/bpb.29.1862
  21. Perini, A. and Mota, I. (1973) The production of IgE and IgG1 antibodies in guinea-pigs immunized with antigen and bacterial lipopolysaccharides. Immunology, 25, 297-305.
  22. Koda, A., Nishiyori, T., Nagai, H., Matsuura, N. and Tsuchiya, H. (1982) Anti-allergic actions of traditional oriental medicine--actions against types I and IV hypersensitivity reactions. Nippon Yakurigaku Zasshi, 80, 31-41. https://doi.org/10.1254/fpj.80.31
  23. Wershil, B.K., Mekori, Y.A., Murakami, T. and Galli, S.J. (1987) 125 I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol., 139, 2605-2614.
  24. Lim, S.H., Shin, S.H., Jang, J.Y., Byun, S.K., Lee, Y.E., Park, D.S., Jeon, J.H., Lee, Y.K., Lee, D.M., Lee, S.R., Kim, J.S., Hwang, B.Y., Ro, J.S., Nam, S.Y., Yun, Y.W. and Kim, Y.B. (2005) Single- and repeated-dose toxicities of Korean red ginseng extract in mice. J. Vet. Med. Biotechnol., 6,187-202.
  25. Park, S.J., Lim, K.H., Noh, J.H., Jeong, E.J., Kim, Y.S., Han, B.C., Lee, S.H. and Moon, K.S. (2013) Subacute oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats. Toxicol. Res., 29, 285-292. https://doi.org/10.5487/TR.2013.29.4.285
  26. Shin, S., Jang, J.Y., Park, D., Yon, J.M., Baek, I.J., Hwang, B.Y., Nam, S.Y., Yun, Y.W., Joo, S.J. and Kim, K.Y. (2010) Korean red ginseng extract does not cause embryo-fetal death or abnormalities in mice. Birth Defects Res. B Dev. Reprod. Toxicol., 89, 78-85.